0001192482-13-000214.txt : 20131211
0001192482-13-000214.hdr.sgml : 20131211
20131211180756
ACCESSION NUMBER: 0001192482-13-000214
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131211
FILED AS OF DATE: 20131211
DATE AS OF CHANGE: 20131211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TETRALOGIC PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001361248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 343 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-889-9900
MAIL ADDRESS:
STREET 1: 343 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gavin Brenda D
CENTRAL INDEX KEY: 0001488182
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36208
FILM NUMBER: 131271962
MAIL ADDRESS:
STREET 1: C/O QUAKER BIOVENTURES
STREET 2: CIRCA CENTRE, 2929 ARCH STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2013-12-11
0
0001361248
TETRALOGIC PHARMACEUTICALS CORP
TLOG
0001488182
Gavin Brenda D
C/O TETRALOGIC PHARMACEUTICALS CORP
343 PHOENIXVILLE PIKE
MALVERN
PA
19355
1
0
0
0
Common Stock
449322
I
By: Quaker BioVentures, L.P.
Common Stock
275245
I
By: Quaker BioVentures Tobacco Fund, L.P.
Common Stock
175518
I
By: BioAdvance Ventures, L.P.
Common Stock Warrants
.85
Common Stock
2553
I
By: Quaker BioVentures, L.P.
Common Stock Warrants
.85
Common Stock
3404
I
By: Quaker BioVentures Tobacco Fund, L.P.
Common Stock Warrants
.85
Common Stock
1779
I
By: BioAdvance Ventures, L.P.
Common Stock Warrants
.85
Common Stock
3063
I
By: Quaker BioVentures, L.P.
Common Stock Warrants
.85
Common Stock
4084
I
By: Quaker BioVentures Tobacco Fund, L.P.
Common Stock Warrants
.85
Common Stock
2135
I
By: BioAdvance Ventures, L.P.
Convertible Notes
Common Stock
I
By: Quaker BioVentures, L.P.
Convertible Notes
Common Stock
I
By: Quaker BioVentures Tobacco Fund, L.P.
Convertible Notes
Common Stock
I
By: BioAdvance Ventures, L.P.
Series C Warrants
6.4022
Common Stock
I
By: Quaker BioVentures, L.P.
Series C Warrants
6.4022
Common Stock
I
By: Quaker BioVentures Tobacco Fund, L.P.
Series C Warrants
6.4022
Common Stock
I
By: BioAdvance Ventures, L.P.
The warrants are immediately exercisable. The warrants expire on the later of 11/25/2019 or five years after the consummation of the Company's initial public offering.
The warrants are immediately exercisable. The warrants expire on the later of 03/10/2020 or five years after the consummation of the Company's initial public offering.
The Convertible Notes will be automatically converted into Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering and have no expiration date.
Warrants will be automatically exercised immediately prior to the closing of the Issuer's initial public offering. Warrants are exercisable for a number of shares of common stock equal to the warrant amount divided by the exercise price and will be net exercised at the initial public offering price.
These securities are owned of record by Quaker BioVentures, L.P., Quaker BioVentures Tobacco Fund, L.P. and BioAdvance Ventures, L.P. Brenda D. Gavin disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.
/s/ Richard L. Sherman, Attorney-In-Fact for Brenda Gavin
2013-12-11